Phreesia (PHR) Financials

$23.41 -0.07 (-0.30%)

Closing price 10/7/2025 03:59 PM Eastern

Extended Trading

$23.42 +0.00 (+0.02%)

As of 10/7/2025 05:52 PM Eastern

Annual Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-38	-45	-91	-27	-118	-176	-137	-59
Consolidated Net Income / (Loss)	-18	-15	-20	-27	-118	-176	-137	-59
Net Income / (Loss) Continuing Operations	-18	-15	-20	-27	-118	-176	-137	-59
Total Pre-Tax Income	-18	-15	-22	-27	-118	-176	-135	-56
Total Operating Income	-15	-9.49	-15	-26	-117	-177	-136	-58
Total Gross Profit	50	63	80	96	132	172	232	285
Total Revenue	80	100	125	149	213	281	356	420
Operating Revenue	80	100	125	149	213	281	356	420
Total Cost of Revenue	30	37	45	52	81	109	124	135
Operating Cost of Revenue	30	37	45	52	81	109	124	135
Total Operating Expenses	65	72	95	122	249	348	369	343
Selling, General & Admin Expense	19	20	30	40	69	80	80	77
Marketing Expense	25	26	32	43	106	151	147	121
Research & Development Expense	11	14	19	23	52	91	112	117
Depreciation Expense	6.83	7.55	8.75	9.77	15	18	18	14
Amortization Expense	2.81	4.04	5.17	6.14	6.32	7.32	12	14
Total Other Income / (Expense), net	-3.64	-5.57	-6.78	-1.57	-1.16	0.89	1.14	2.29
Interest Expense	3.64	3.50	2.45	1.57	1.08	0.00	1.12	0.00
Interest & Investment Income	-	-	-	-	-	1.06	2.21	0.33
Other Income / (Expense), net	0.00	-2.07	-4.33	0.00	-0.08	-0.18	0.04	1.96
Income Tax Expense	0.00	0.00	-1.78	0.05	0.18	0.48	1.54	2.72
Basic Earnings per Share	($24.81)	($24.53)	($4.50)	($0.69)	($2.37)	($3.36)	($2.51)	($1.02)
Weighted Average Basic Shares Outstanding	1.54M	1.84M	20.30M	39.52M	49.89M	52.44M	54.56M	57.59M
Diluted Earnings per Share	($24.81)	($24.53)	($4.50)	($0.69)	($2.37)	($3.36)	($2.51)	($1.02)
Weighted Average Diluted Shares Outstanding	1.54M	1.84M	20.30M	39.52M	49.89M	52.44M	54.56M	57.59M
Weighted Average Basic & Diluted Shares Outstanding	1.54M	1.84M	20.30M	39.52M	51.95M	53.36M	56.39M	58.77M

This table shows Phreesia's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-47	-40	-38	-38	-37	-32	-31	-20	-18	-14	-6.39
Consolidated Net Income / (Loss)	-47	-40	-38	-38	-37	-32	-31	-20	-18	-14	-6.39
Net Income / (Loss) Continuing Operations	-47	-40	-38	-38	-37	-32	-31	-20	-18	-14	-6.39
Total Pre-Tax Income	-47	-40	-38	-37	-36	-32	-30	-19	-17	-14	-5.38
Total Operating Income	-46	-40	-40	-38	-37	-32	-30	-19	-17	-14	-7.61
Total Gross Profit	40	46	49	53	56	61	63	67	69	72	76
Total Revenue	68	73	77	84	86	92	95	101	102	107	110
Operating Revenue	68	73	77	84	86	92	95	101	102	107	110
Total Cost of Revenue	27	27	28	31	30	31	32	34	33	35	34
Operating Cost of Revenue	27	27	28	31	30	31	32	34	33	35	34
Total Operating Expenses	87	86	88	91	92	93	93	87	87	86	84
Selling, General & Admin Expense	20	20	20	20	21	20	19	19	19	20	18
Marketing Expense	38	37	36	37	37	36	36	32	30	30	29
Research & Development Expense	23	23	25	26	27	29	30	29	30	29	30
Depreciation Expense	4.22	4.87	4.63	4.50	4.24	4.48	4.35	3.52	3.92	3.57	3.17
Amortization Expense	1.60	1.82	2.30	2.49	2.54	2.98	3.90	3.15	3.38	3.52	3.65
Total Other Income / (Expense), net	-0.17	-0.15	1.62	0.68	0.84	0.48	-0.85	0.21	-0.04	-0.12	2.24
Interest & Investment Income	-	-	-	0.72	0.79	0.52	0.18	0.24	0.05	0.03	0.02
Other Income / (Expense), net	0.04	-0.21	0.03	-0.04	0.05	-0.05	0.08	-0.03	-0.09	-0.14	2.22
Income Tax Expense	0.21	0.21	-0.17	0.31	0.65	0.37	0.22	0.51	0.75	0.44	1.01
Basic Earnings per Share	($0.89)	($0.76)	($0.72)	($0.70)	($0.68)	($0.58)	($0.55)	($0.35)	($0.31)	($0.25)	($0.11)
Weighted Average Basic Shares Outstanding	52.33M	52.61M	52.44M	53.35M	53.79M	55.25M	54.56M	56.67M	57.50M	57.89M	57.59M
Diluted Earnings per Share	($0.89)	($0.76)	($0.72)	($0.70)	($0.68)	($0.58)	($0.55)	($0.35)	($0.31)	($0.25)	($0.11)
Weighted Average Diluted Shares Outstanding	52.33M	52.61M	52.44M	53.35M	53.79M	55.25M	54.56M	56.67M	57.50M	57.89M	57.59M
Weighted Average Basic & Diluted Shares Outstanding	52.53M	52.75M	53.36M	53.66M	55.21M	55.63M	56.39M	57.40M	57.77M	58.12M	58.77M

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Net Change in Cash & Equivalents	8.18	-8.96	89	128	95	-137	-89	-3.30
Net Cash From Operating Activities	-11	-2.13	0.83	2.89	-75	-90	-32	32
Net Cash From Continuing Operating Activities	-11	-2.13	0.83	2.89	-75	-90	-32	32
Net Income / (Loss) Continuing Operations	-18	-15	-20	-27	-118	-176	-137	-59
Consolidated Net Income / (Loss)	-18	-15	-20	-27	-118	-176	-137	-59
Depreciation Expense	9.64	12	14	16	21	25	29	28
Amortization Expense	2.29	2.44	2.42	2.41	2.50	2.01	1.38	2.05
Non-Cash Adjustments To Reconcile Net Income	-0.37	1.59	11	16	38	62	75	67
Changes in Operating Assets and Liabilities, net	-4.51	-2.69	-6.53	-4.16	-18	-3.43	-1.41	-6.28
Net Cash From Investing Activities	-12	-11	-12	-25	-65	-26	-40	-24
Net Cash From Continuing Investing Activities	-12	-11	-12	-25	-65	-26	-40	-24
Purchase of Property, Plant & Equipment	-12	-9.83	-12	-19	-31	-26	-25	-24
Acquisitions	0.00	-1.19	-	-6.51	-34	0.00	-15	0.00
Net Cash From Financing Activities	31	4.19	100	151	235	-21	-17	-11
Net Cash From Continuing Financing Activities	31	4.19	100	151	235	-21	-17	-11
Repayment of Debt	-24	-8.30	-39	-23	-1.16	-0.61	-2.68	-1.35
Issuance of Debt	22	15	30	-	0.00	0.00	1.69	0.00
Issuance of Common Equity	0.00	0.00	131	175	248	3.32	3.21	2.92
Other Financing Activities, net	0.15	-2.11	-0.09	-1.20	-12	-24	-19	-13
Effect of Exchange Rate Changes	-	-	-	-	-	0.00	0.00	-0.11
Cash Interest Paid	2.80	2.80	2.31	1.47	0.80	0.76	1.31	2.19
Cash Income Taxes Paid	-	0.00	0.00	0.06	0.05	0.04	0.04	3.07

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Net Change in Cash & Equivalents	-28	-31	-33	-27	-22	-24	-16	-7.99	2.27	-0.06	2.48
Net Cash From Operating Activities	-20	-21	-16	-14	-9.33	-6.31	-3.08	-0.72	11	5.79	16
Net Cash From Continuing Operating Activities	-20	-21	-16	-14	-9.33	-6.31	-3.08	-0.72	11	5.79	16
Net Income / (Loss) Continuing Operations	-47	-40	-38	-38	-37	-32	-31	-20	-18	-14	-6.39
Consolidated Net Income / (Loss)	-47	-40	-38	-38	-37	-32	-31	-20	-18	-14	-6.39
Depreciation Expense	5.82	6.68	6.92	6.99	6.78	7.46	8.25	6.67	7.30	7.09	6.82
Amortization Expense	0.51	0.50	0.46	0.43	0.36	0.32	0.27	0.25	0.24	1.38	0.17
Non-Cash Adjustments To Reconcile Net Income	16	16	16	18	19	19	20	17	17	18	16
Changes in Operating Assets and Liabilities, net	4.99	-3.46	-1.43	-1.33	1.30	-0.84	-0.54	-5.28	4.98	-6.01	0.03
Net Cash From Investing Activities	-5.85	-6.73	-6.60	-6.08	-9.72	-16	-8.16	-5.45	-7.40	-4.18	-7.06
Net Cash From Continuing Investing Activities	-5.85	-6.73	-6.60	-6.08	-9.72	-16	-8.16	-5.45	-7.40	-4.18	-7.06
Purchase of Property, Plant & Equipment	-5.85	-6.73	-6.60	-6.08	-5.84	-5.31	-7.86	-5.45	-7.40	-4.18	-7.06
Net Cash From Financing Activities	-2.77	-3.66	-10	-7.18	-3.04	-2.28	-4.61	-1.83	-1.38	-1.65	-6.63
Net Cash From Continuing Financing Activities	-2.77	-3.66	-10	-7.18	-3.04	-2.28	-4.61	-1.83	-1.38	-1.65	-6.63
Repayment of Debt	-0.50	-	-	0.00	-0.30	-0.27	-2.11	-0.44	-0.30	-0.30	-0.31
Issuance of Common Equity	0.74	0.88	0.49	0.97	0.90	0.92	0.43	0.91	0.69	0.84	0.48
Other Financing Activities, net	-3.00	-4.55	-11	-8.15	-5.33	-2.93	-2.93	-2.30	-1.78	-2.19	-6.79
Effect of Exchange Rate Changes	-	-	-	0.00	-	-	-	-0.00	-0.01	-0.01	-0.09
Cash Interest Paid	0.32	0.20	0.12	0.06	0.30	0.30	0.66	0.48	0.38	0.60	0.74
Cash Income Taxes Paid	-	-	-	0.04	0.01	-0.01	-0.01	1.59	0.42	0.55	0.51

This table presents Phreesia's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Total Assets	59	159	327	494	370	370	388
Total Current Assets	33	132	272	386	262	196	203
Cash & Equivalents	1.54	90	219	314	177	88	84
Accounts Receivable	16	22	29	40	51	65	74
Prepaid Expenses	3.81	5.16	7.25	11	11	14	16
Other Current Assets	12	14	17	21	24	29	30
Plant, Property, & Equipment, net	14	14	0.00	0.00	22	17	24
Total Noncurrent Assets	12	13	54	108	86	158	161
Goodwill	0.25	0.25	8.31	34	34	76	76
Intangible Assets	9.25	9.93	13	30	47	78	81
Other Noncurrent Operating Assets	2.23	1.77	32	44	5.58	4.13	4.73
Total Liabilities & Shareholders' Equity	59	159	327	494	370	370	388
Total Liabilities	64	57	63	77	82	119	124
Total Current Liabilities	28	35	55	68	79	110	114
Short-Term Debt	1.97	2.32	4.86	5.82	5.17	6.06	8.04
Accounts Payable	3.75	6.02	4.39	5.12	11	8.48	5.62
Accrued Expenses	5.51	9.24	18	20	22	37	37
Current Deferred Revenue	6.49	5.40	11	16	18	24	33
Other Current Liabilities	10	12	17	21	24	34	30
Total Noncurrent Liabilities	36	22	8.37	8.76	3.20	8.76	9.58
Long-Term Debt	28	22	6.47	7.42	2.73	5.40	8.15
Noncurrent Deferred Revenue	-	-	-	0.07	0.13	0.10	0.12
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	0.00	0.27	0.48
Other Noncurrent Operating Liabilities	5.50	0.00	1.90	1.28	0.35	2.99	0.83
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-211	102	263	417	288	251	265
Total Preferred & Common Equity	-211	102	263	417	288	251	265
Preferred Stock	-	-	-	-	0.00	0.00	0.00
Total Common Equity	-211	102	263	417	288	251	265
Common Stock	0.02	387	580	861	927	1,040	1,112
Retained Earnings	-211	-284	-312	-430	-606	-743	-801
Treasury Stock	0.00	-0.40	-4.97	-14	-34	-46	-46
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	0.00	-0.05

This table presents Phreesia's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	10/31/2021	4/30/2022	7/31/2022	10/31/2022	4/30/2023	7/31/2023	10/31/2023	4/30/2024	7/31/2024	10/31/2024
Total Assets	529	459	426	397	354	340	375	372	362	376
Total Current Assets	464	349	316	287	240	219	199	191	181	190
Cash & Equivalents	400	269	241	210	150	128	103	80	82	82
Accounts Receivable	35	46	47	44	53	54	57	66	61	71
Prepaid Expenses	10	11	7.72	11	10	12	14	14	12	11
Other Current Assets	18	23	21	22	27	26	25	31	26	25
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	20	22	21	26
Total Noncurrent Assets	65	110	109	110	114	121	156	159	160	160
Goodwill	8.21	34	34	34	34	41	75	76	76	76
Intangible Assets	16	35	40	44	49	54	77	79	80	80
Other Noncurrent Operating Assets	40	41	36	33	31	26	3.28	4.23	4.86	3.98
Total Liabilities & Shareholders' Equity	529	459	426	397	354	340	375	372	362	376
Total Liabilities	71	78	78	77	90	93	110	119	111	121
Total Current Liabilities	65	71	72	73	83	85	98	108	102	109
Short-Term Debt	4.60	6.10	5.72	5.48	6.98	7.11	6.75	7.75	7.16	8.87
Accounts Payable	12	5.87	10	11	7.60	7.95	11	6.68	6.98	16
Accrued Expenses	19	18	18	20	23	28	28	33	33	29
Current Deferred Revenue	12	18	17	14	18	16	22	24	21	22
Other Current Liabilities	17	23	21	22	27	26	30	37	34	33
Total Noncurrent Liabilities	6.25	7.09	5.58	4.23	7.26	8.55	12	11	8.90	12
Long-Term Debt	5.13	6.00	4.93	3.77	6.69	8.06	6.85	8.69	7.30	10
Noncurrent Deferred Revenue	-	0.15	0.01	0.00	0.18	0.10	0.10	0.08	0.06	0.20
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	0.14	0.18	0.22	0.33	0.39	0.45
Other Noncurrent Operating Liabilities	1.12	0.95	0.63	0.46	0.26	0.22	4.46	1.96	1.15	0.97
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	458	381	348	320	264	247	265	253	251	255
Total Preferred & Common Equity	458	381	348	320	264	247	265	253	251	255
Preferred Stock	-	-	-	-	-	-	-	0.00	0.00	0.00
Total Common Equity	458	381	348	320	264	247	265	253	251	255
Common Stock	850	881	897	912	948	972	1,022	1,061	1,078	1,095
Retained Earnings	-383	-481	-528	-568	-644	-680	-712	-763	-781	-795
Treasury Stock	-8.56	-19	-20	-24	-41	-44	-46	-46	-46	-46
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-	0.00	-0.00	-0.01

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	25.12%	24.92%	19.15%	43.42%	31.74%	26.84%	17.83%
EBITDA Growth	0.00%	194.53%	-232.71%	-123.89%	-1,166.93%	-60.50%	29.34%	75.18%
EBIT Growth	0.00%	20.55%	-69.81%	-30.78%	-355.38%	-51.18%	22.80%	58.85%
NOPAT Growth	0.00%	34.76%	-61.13%	-67.81%	-355.05%	-51.14%	22.70%	57.43%
Net Income Growth	0.00%	17.21%	-34.73%	-34.49%	-332.95%	-49.07%	22.29%	57.24%
EPS Growth	0.00%	1.13%	81.66%	84.67%	-243.48%	-41.77%	25.30%	59.36%
Operating Cash Flow Growth	0.00%	80.88%	138.78%	249.88%	-2,685.12%	-20.63%	64.07%	200.01%
Free Cash Flow Firm Growth	0.00%	0.00%	39.63%	-93.40%	-271.26%	11.72%	-20.63%	59.14%
Invested Capital Growth	0.00%	0.00%	34.86%	57.73%	108.94%	1.99%	47.34%	12.20%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	6.44%	8.23%	7.08%	5.45%	3.62%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-78.48%	-63.51%	4.92%	9.77%	46.28%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-13.72%	-49.12%	3.69%	7.01%	30.03%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-16.36%	-48.85%	3.71%	6.98%	27.44%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-19.37%	-48.06%	4.57%	5.11%	29.30%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	6.15%	6.34%	30.14%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	119.45%	3,221.84%	-128.79%	19.68%	28.37%	148.19%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-84.09%	30.48%	3.58%	15.24%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	24.91%	73.54%	-0.81%	0.32%	2.48%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	62.71%	62.96%	64.16%	64.77%	61.83%	61.10%	65.19%	67.86%
EBITDA Margin	-3.28%	2.48%	-2.63%	-4.94%	-43.66%	-53.19%	-29.63%	-6.24%
Operating Margin	-18.23%	-9.50%	-12.26%	-17.27%	-54.78%	-62.85%	-38.30%	-13.84%
EBIT Margin	-18.22%	-11.57%	-15.73%	-17.27%	-54.82%	-62.91%	-38.29%	-13.37%
Profit (Net Income) Margin	-22.79%	-15.08%	-16.26%	-18.36%	-55.41%	-62.71%	-38.42%	-13.94%
Tax Burden Percent	100.00%	100.00%	91.94%	100.18%	100.15%	100.28%	101.14%	104.87%
Interest Burden Percent	125.04%	130.31%	112.46%	106.13%	100.93%	99.40%	99.20%	99.41%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-50.62%	-34.73%	-39.38%	-94.77%	-104.85%	-64.90%	-21.85%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-105.37%	18.96%	-32.57%	-80.44%	-82.45%	-31.12%	2.93%
Return on Net Nonoperating Assets (RNNOA)	0.00%	722.43%	-6.95%	24.43%	60.05%	54.88%	14.13%	-0.82%
Return on Equity (ROE)	0.00%	671.81%	-41.68%	-14.95%	-34.72%	-49.96%	-50.77%	-22.67%
Cash Return on Invested Capital (CROIC)	0.00%	-250.62%	-64.42%	-84.18%	-165.29%	-106.82%	-103.18%	-33.35%
Operating Return on Assets (OROA)	0.00%	-19.50%	-18.01%	-10.58%	-28.47%	-40.88%	-36.86%	-14.80%
Return on Assets (ROA)	0.00%	-25.42%	-18.62%	-11.24%	-28.78%	-40.75%	-36.98%	-15.43%
Return on Common Equity (ROCE)	0.00%	31,608.97%	46.70%	-14.95%	-34.72%	-49.96%	-50.77%	-22.67%
Return on Equity Simple (ROE_SIMPLE)	0.00%	7.14%	-19.92%	-10.37%	-28.32%	-61.20%	-54.44%	-22.10%
Net Operating Profit after Tax (NOPAT)	-10	-6.65	-11	-18	-82	-124	-96	-41
NOPAT Margin	-12.76%	-6.65%	-8.58%	-12.09%	-38.35%	-44.00%	-26.81%	-9.69%
Net Nonoperating Expense Percent (NNEP)	0.00%	54.75%	-53.68%	-6.81%	-14.33%	-22.40%	-33.78%	-24.79%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-41.79%	-36.34%	-14.47%
Cost of Revenue to Revenue	37.29%	37.04%	35.84%	35.23%	38.17%	38.90%	34.81%	32.14%
SG&A Expenses to Revenue	23.60%	20.10%	24.41%	27.21%	32.21%	28.62%	22.43%	18.25%
R&D to Revenue	14.25%	14.36%	14.92%	15.22%	24.51%	32.48%	31.53%	27.96%
Operating Expenses to Revenue	80.94%	72.47%	76.42%	82.03%	116.62%	123.95%	103.50%	81.70%
Earnings before Interest and Taxes (EBIT)	-15	-12	-20	-26	-117	-177	-136	-56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2.62	2.47	-3.28	-7.35	-93	-149	-106	-26
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	10.92	10.95	3.83	6.87	5.64	6.25
Price to Tangible Book Value (P/TBV)	0.00	0.00	12.13	11.92	4.52	9.53	14.49	15.31
Price to Revenue (P/Rev)	2.09	1.67	8.91	19.39	7.50	7.04	3.98	3.94
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	15.40	29.54	47.90	11.12	15.20	7.65	8.06
Enterprise Value to Revenue (EV/Rev)	0.00	4.05	8.38	18.00	6.09	6.44	3.77	3.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	163.53	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	1,266.33	925.93	0.00	0.00	0.00	48.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	-7.20	0.23	0.04	0.03	0.03	0.05	0.06
Long-Term Debt to Equity	0.00	-6.76	0.21	0.02	0.02	0.01	0.02	0.03
Financial Leverage	0.00	-6.86	-0.37	-0.75	-0.75	-0.67	-0.45	-0.28
Leverage Ratio	0.00	-13.22	2.24	1.33	1.21	1.23	1.37	1.47
Compound Leverage Factor	0.00	-17.22	2.52	1.41	1.22	1.22	1.36	1.46
Debt to Total Capital	0.00%	116.13%	18.98%	4.13%	3.08%	2.67%	4.36%	5.76%
Short-Term Debt to Total Capital	0.00%	7.07%	1.85%	1.77%	1.35%	1.75%	2.30%	2.86%
Long-Term Debt to Total Capital	0.00%	109.06%	17.13%	2.36%	1.72%	0.92%	2.05%	2.90%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	742.74%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-758.87%	81.02%	95.87%	96.92%	97.33%	95.64%	94.24%
Debt to EBITDA	0.00	13.06	-7.27	-1.54	-0.14	-0.05	-0.11	-0.62
Net Debt to EBITDA	0.00	12.43	20.25	28.23	3.23	1.13	0.72	2.60
Long-Term Debt to EBITDA	0.00	12.26	-6.56	-0.88	-0.08	-0.02	-0.05	-0.31
Debt to NOPAT	0.00	-4.86	-2.23	-0.63	-0.16	-0.06	-0.12	-0.40
Net Debt to NOPAT	0.00	-4.63	6.21	11.54	3.68	1.37	0.80	1.67
Long-Term Debt to NOPAT	0.00	-4.56	-2.01	-0.36	-0.09	-0.02	-0.06	-0.20
Altman Z-Score	0.00	-2.26	10.33	26.96	11.63	11.91	4.37	6.02
Noncontrolling Interest Sharing Ratio	0.00%	-4,605.04%	212.04%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.19	3.72	4.95	5.65	3.32	1.78	1.78
Quick Ratio	0.00	0.63	3.18	4.51	5.17	2.89	1.38	1.38
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-33	-20	-38	-143	-126	-152	-62
Operating Cash Flow to CapEx	-93.12%	-21.66%	6.70%	15.56%	-242.53%	-343.94%	-129.01%	134.42%
Free Cash Flow to Firm to Interest Expense	0.00	-9.39	-8.12	-24.42	-131.57	0.00	-135.86	0.00
Operating Cash Flow to Interest Expense	-3.06	-0.61	0.34	1.84	-68.92	0.00	-28.96	0.00
Operating Cash Flow Less CapEx to Interest Expense	-6.34	-3.41	-4.70	-9.97	-97.34	0.00	-51.41	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.69	1.14	0.61	0.52	0.65	0.96	1.11
Accounts Receivable Turnover	0.00	6.21	6.56	5.83	6.15	6.13	6.13	6.06
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	7.03	8.70	0.00	0.00	0.00	18.47	20.70
Accounts Payable Turnover	0.00	9.87	9.16	10.07	17.12	13.70	12.84	19.14
Days Sales Outstanding (DSO)	0.00	58.73	55.65	62.64	59.32	59.55	59.55	60.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	37.00	39.86	36.25	21.32	26.65	28.43	19.07
Cash Conversion Cycle (CCC)	0.00	21.74	15.79	26.39	38.00	32.90	31.12	41.13
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	26	35	56	117	119	175	197
Invested Capital Turnover	0.00	7.61	4.05	3.26	2.47	2.38	2.42	2.26
Increase / (Decrease) in Invested Capital	0.00	26	9.16	20	61	2.32	56	21
Enterprise Value (EV)	0.00	404	1,046	2,676	1,298	1,809	1,342	1,586
Market Capitalization	167	167	1,112	2,883	1,598	1,977	1,418	1,654
Book Value per Share	$0.00	($114.35)	$2.84	$5.96	$8.14	$5.46	$4.52	$4.56
Tangible Book Value per Share	$0.00	($119.50)	$2.55	$5.48	$6.89	$3.93	$1.76	$1.86
Total Capital	0.00	28	126	275	431	296	263	281
Total Debt	0.00	32	24	11	13	7.90	11	16
Total Long-Term Debt	0.00	30	22	6.47	7.42	2.73	5.40	8.15
Net Debt	0.00	31	-66	-207	-301	-169	-76	-68
Capital Expenditures (CapEx)	12	9.83	12	19	31	26	25	24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	5.81	8.19	3.36	9.93	12	4.10	13
Debt-free Net Working Capital (DFNWC)	0.00	7.35	99	222	324	189	92	97
Net Working Capital (NWC)	0.00	5.39	96	217	318	183	86	89
Net Nonoperating Expense (NNE)	8.00	8.42	9.58	9.32	36	53	41	18
Net Nonoperating Obligations (NNO)	0.00	31	-66	-207	-301	-169	-76	-68
Total Depreciation and Amortization (D&A)	12	14	16	18	24	27	31	30
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	5.82%	6.57%	2.26%	4.66%	4.23%	1.15%	3.12%
Debt-free Net Working Capital to Revenue	0.00%	7.36%	78.94%	149.41%	151.82%	67.13%	25.71%	23.18%
Net Working Capital to Revenue	0.00%	5.39%	77.08%	146.14%	149.09%	65.29%	24.01%	21.26%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($4.50)	($0.69)	($2.37)	($3.36)	($2.51)	($1.02)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	37.52M	44.90M	49.89M	52.44M	54.56M	57.59M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($4.50)	($0.69)	($2.37)	($3.36)	($2.51)	($1.02)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	37.52M	44.90M	49.89M	52.44M	54.56M	57.59M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($4.50)	($0.69)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	20.30M	39.52M	51.95M	53.36M	56.39M	58.77M
Normalized Net Operating Profit after Tax (NOPAT)	-10	-6.65	-11	-18	-82	-124	-96	-41
Normalized NOPAT Margin	-12.76%	-6.65%	-8.58%	-12.09%	-38.35%	-44.00%	-26.81%	-9.69%
Pre Tax Income Margin	-22.79%	-15.08%	-17.69%	-18.32%	-55.33%	-62.53%	-37.99%	-13.29%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.99	-3.30	-8.03	-16.32	-107.84	0.00	-122.03	0.00
NOPAT to Interest Expense	-2.80	-1.90	-4.38	-11.42	-75.44	0.00	-85.45	0.00
EBIT Less CapEx to Interest Expense	-7.28	-6.11	-13.07	-28.13	-136.25	0.00	-144.48	0.00
NOPAT Less CapEx to Interest Expense	-6.08	-4.70	-9.42	-23.23	-103.85	0.00	-107.90	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	-73.70%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-1.29%	-104.33%	-1.06%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	33.05%	30.74%	32.00%	32.34%	26.47%	25.33%	24.05%	20.72%	18.97%	16.57%	15.45%
EBITDA Growth	-122.47%	-9.51%	19.28%	30.93%	25.55%	25.98%	35.27%	58.97%	67.20%	77.31%	107.62%
EBIT Growth	-93.73%	-11.62%	14.55%	25.05%	20.29%	19.81%	25.86%	48.74%	53.10%	56.42%	81.71%
NOPAT Growth	-94.62%	-11.39%	14.59%	25.09%	20.24%	19.51%	25.71%	48.76%	53.40%	56.80%	74.26%
Net Income Growth	-91.51%	-10.52%	18.15%	26.76%	21.30%	20.48%	19.40%	47.45%	51.01%	54.91%	79.15%
EPS Growth	-85.42%	-7.04%	23.40%	29.29%	23.60%	23.68%	23.61%	50.00%	54.41%	56.90%	80.00%
Operating Cash Flow Growth	-194.89%	15.41%	58.14%	59.39%	52.98%	69.59%	80.64%	94.72%	218.54%	191.68%	628.14%
Free Cash Flow Firm Growth	-194.64%	-69.53%	67.71%	69.26%	55.33%	4.17%	-155.24%	-153.12%	-46.55%	65.22%	65.32%
Invested Capital Growth	108.42%	78.43%	1.99%	2.73%	13.62%	45.69%	47.34%	48.73%	36.79%	9.83%	12.20%
Revenue Q/Q Growth	7.12%	7.72%	4.76%	9.48%	2.37%	6.74%	3.70%	6.54%	0.89%	4.59%	2.70%
EBITDA Q/Q Growth	9.56%	17.83%	1.35%	5.78%	2.52%	18.31%	13.73%	40.28%	22.06%	43.50%	128.99%
EBIT Q/Q Growth	8.55%	13.55%	0.59%	4.63%	2.74%	13.04%	8.09%	34.05%	11.02%	19.19%	61.43%
NOPAT Q/Q Growth	8.42%	14.08%	-0.01%	4.80%	2.50%	13.29%	7.70%	34.34%	11.32%	19.62%	45.01%
Net Income Q/Q Growth	8.83%	14.02%	5.34%	1.29%	2.04%	13.13%	4.05%	35.65%	8.67%	20.04%	55.63%
EPS Q/Q Growth	10.10%	14.61%	5.26%	2.78%	2.86%	14.71%	5.17%	36.36%	11.43%	19.35%	56.00%
Operating Cash Flow Q/Q Growth	41.00%	-4.56%	23.37%	14.09%	31.69%	32.38%	51.22%	76.58%	1,634.12%	-47.70%	181.00%
Free Cash Flow Firm Q/Q Growth	3.39%	14.25%	62.55%	0.90%	-40.36%	-83.97%	0.26%	1.72%	18.74%	56.34%	0.54%
Invested Capital Q/Q Growth	-4.63%	1.37%	-0.81%	7.13%	5.49%	29.98%	0.32%	8.13%	-2.98%	4.36%	2.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	59.59%	62.61%	63.49%	63.03%	64.70%	66.23%	66.56%	66.39%	67.87%	67.66%	69.40%
EBITDA Margin	-58.90%	-44.93%	-42.31%	-36.41%	-34.67%	-26.53%	-22.08%	-12.37%	-9.56%	-5.16%	1.46%
Operating Margin	-68.27%	-54.46%	-51.98%	-45.20%	-43.06%	-34.98%	-31.13%	-19.19%	-16.87%	-12.96%	-6.94%
EBIT Margin	-68.22%	-54.75%	-51.95%	-45.25%	-43.00%	-35.03%	-31.05%	-19.22%	-16.95%	-13.10%	-4.92%
Profit (Net Income) Margin	-68.83%	-54.95%	-49.64%	-44.76%	-42.84%	-34.86%	-32.26%	-19.48%	-17.64%	-13.49%	-5.83%
Tax Burden Percent	100.46%	100.52%	99.55%	100.82%	101.79%	101.18%	100.71%	102.65%	104.34%	103.17%	118.86%
Interest Burden Percent	100.45%	99.85%	96.00%	98.11%	97.87%	98.37%	103.17%	98.77%	99.73%	99.81%	99.65%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-133.76%	-106.81%	-86.72%	-75.80%	-76.12%	-56.12%	-52.75%	-31.65%	-28.91%	-20.04%	-10.96%
ROIC Less NNEP Spread (ROIC-NNEP)	-129.43%	-102.65%	-82.40%	-70.20%	-69.76%	-49.56%	-44.63%	-25.49%	-22.28%	-13.85%	-9.49%
Return on Net Nonoperating Assets (RNNOA)	102.28%	77.95%	54.85%	42.81%	40.13%	24.58%	20.26%	9.83%	8.04%	4.07%	2.65%
Return on Equity (ROE)	-31.48%	-28.86%	-31.87%	-32.99%	-35.99%	-31.54%	-32.48%	-21.81%	-20.87%	-15.98%	-8.31%
Cash Return on Invested Capital (CROIC)	-213.58%	-193.42%	-106.82%	-93.85%	-98.27%	-106.86%	-103.18%	-91.27%	-74.27%	-39.92%	-33.35%
Operating Return on Assets (OROA)	-34.23%	-31.01%	-33.76%	-33.56%	-35.83%	-30.66%	-29.88%	-19.78%	-18.81%	-14.14%	-5.44%
Return on Assets (ROA)	-34.54%	-31.12%	-32.26%	-33.19%	-35.70%	-30.52%	-31.05%	-20.06%	-19.58%	-14.56%	-6.45%
Return on Common Equity (ROCE)	-31.48%	-28.86%	-31.87%	-32.99%	-35.99%	-31.54%	-32.48%	-21.81%	-20.87%	-15.98%	-8.31%
Return on Equity Simple (ROE_SIMPLE)	-51.87%	-57.62%	0.00%	-61.62%	-61.73%	-54.52%	0.00%	-47.11%	-39.92%	-32.52%	0.00%
Net Operating Profit after Tax (NOPAT)	-32	-28	-28	-27	-26	-22	-21	-14	-12	-9.69	-5.33
NOPAT Margin	-47.79%	-38.12%	-36.39%	-31.64%	-30.14%	-24.48%	-21.79%	-13.43%	-11.81%	-9.07%	-4.86%
Net Nonoperating Expense Percent (NNEP)	-4.33%	-4.16%	-4.33%	-5.60%	-6.36%	-6.56%	-8.12%	-6.15%	-6.62%	-6.19%	-1.47%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-9.42%	-	-	-	-7.88%	-	-	-	-1.90%
Cost of Revenue to Revenue	40.41%	37.39%	36.51%	36.97%	35.30%	33.77%	33.44%	33.61%	32.13%	32.34%	30.60%
SG&A Expenses to Revenue	29.58%	26.81%	25.93%	23.71%	24.45%	22.09%	19.81%	18.82%	19.09%	18.38%	16.79%
R&D to Revenue	33.22%	31.01%	33.16%	31.57%	32.01%	31.16%	31.43%	28.53%	28.93%	27.45%	27.01%
Operating Expenses to Revenue	127.86%	117.07%	115.47%	108.23%	107.75%	101.21%	97.69%	85.58%	84.73%	80.62%	76.34%
Earnings before Interest and Taxes (EBIT)	-46	-40	-40	-38	-37	-32	-29	-19	-17	-14	-5.40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-40	-33	-32	-31	-30	-24	-21	-13	-9.76	-5.52	1.60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.52	4.48	6.87	6.40	6.89	2.85	5.64	4.63	5.70	4.15	6.25
Price to Tangible Book Value (P/TBV)	4.46	5.91	9.53	9.34	11.18	6.71	14.49	11.95	14.94	10.74	15.31
Price to Revenue (P/Rev)	5.01	5.47	7.04	5.60	5.33	2.23	3.98	3.13	3.67	2.61	3.94
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.42	10.29	15.20	12.17	11.82	3.80	7.65	5.83	7.42	5.18	8.06
Enterprise Value to Revenue (EV/Rev)	4.07	4.71	6.44	5.15	4.98	1.97	3.77	2.96	3.50	2.45	3.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1,433.55	76.19	48.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.03	0.03	0.05	0.06	0.05	0.05	0.07	0.06	0.08	0.06
Long-Term Debt to Equity	0.01	0.01	0.01	0.03	0.03	0.03	0.02	0.03	0.03	0.04	0.03
Financial Leverage	-0.79	-0.76	-0.67	-0.61	-0.58	-0.50	-0.45	-0.39	-0.36	-0.29	-0.28
Leverage Ratio	1.17	1.19	1.23	1.26	1.29	1.32	1.37	1.41	1.41	1.45	1.47
Compound Leverage Factor	1.18	1.19	1.18	1.24	1.26	1.30	1.42	1.39	1.41	1.44	1.46
Debt to Total Capital	2.97%	2.81%	2.67%	4.93%	5.78%	4.89%	4.36%	6.11%	5.44%	7.00%	5.76%
Short-Term Debt to Total Capital	1.59%	1.66%	1.75%	2.52%	2.71%	2.43%	2.30%	2.88%	2.69%	3.24%	2.86%
Long-Term Debt to Total Capital	1.37%	1.14%	0.92%	2.41%	3.07%	2.46%	2.05%	3.23%	2.75%	3.76%	2.90%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	97.03%	97.19%	97.33%	95.07%	94.22%	95.11%	95.64%	93.89%	94.56%	93.00%	94.24%
Debt to EBITDA	-0.07	-0.06	-0.05	-0.10	-0.12	-0.12	-0.11	-0.19	-0.21	-0.39	-0.62
Net Debt to EBITDA	1.49	1.27	1.13	1.00	0.90	0.77	0.72	0.72	1.00	1.28	2.60
Long-Term Debt to EBITDA	-0.03	-0.02	-0.02	-0.05	-0.06	-0.06	-0.05	-0.10	-0.11	-0.21	-0.31
Debt to NOPAT	-0.08	-0.07	-0.06	-0.12	-0.14	-0.13	-0.12	-0.20	-0.21	-0.34	-0.40
Net Debt to NOPAT	1.83	1.56	1.37	1.19	1.04	0.87	0.80	0.76	0.98	1.12	1.67
Long-Term Debt to NOPAT	-0.04	-0.03	-0.02	-0.06	-0.07	-0.07	-0.06	-0.11	-0.11	-0.18	-0.20
Altman Z-Score	8.67	10.16	13.13	9.71	9.19	2.39	5.32	4.11	5.91	3.48	6.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.40	3.94	3.32	2.89	2.58	2.02	1.78	1.76	1.77	1.74	1.78
Quick Ratio	4.00	3.49	2.89	2.44	2.14	1.63	1.38	1.35	1.40	1.40	1.38
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-94	-81	-30	-30	-42	-77	-77	-76	-62	-27	-27
Operating Cash Flow to CapEx	-339.08%	-308.38%	-240.93%	-224.69%	-159.70%	-118.81%	-39.14%	-13.24%	149.41%	138.33%	230.32%
Free Cash Flow to Firm to Interest Expense	-456.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-96.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-124.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.57	0.65	0.74	0.83	0.88	0.96	1.03	1.11	1.08	1.11
Accounts Receivable Turnover	6.34	6.57	6.13	6.07	6.33	6.64	6.13	6.27	6.77	6.29	6.06
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	18.47	0.00	0.00	17.66	20.70
Accounts Payable Turnover	12.51	9.13	13.70	16.88	12.93	10.92	12.84	17.78	17.36	9.95	19.14
Days Sales Outstanding (DSO)	57.55	55.52	59.55	60.12	57.64	54.98	59.55	58.21	53.91	58.04	60.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	29.17	39.98	26.65	21.62	28.23	33.42	28.43	20.52	21.02	36.70	19.07
Cash Conversion Cycle (CCC)	28.38	15.54	32.90	38.49	29.41	21.56	31.12	37.69	32.88	21.34	41.13
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	118	120	119	128	135	175	175	190	184	192	197
Invested Capital Turnover	2.80	2.80	2.38	2.40	2.53	2.29	2.42	2.36	2.45	2.21	2.26
Increase / (Decrease) in Invested Capital	62	53	2.32	3.39	16	55	56	62	49	17	21
Enterprise Value (EV)	997	1,235	1,809	1,552	1,590	664	1,342	1,106	1,365	994	1,586
Market Capitalization	1,227	1,435	1,977	1,688	1,702	754	1,418	1,169	1,432	1,057	1,654
Book Value per Share	$6.67	$6.10	$5.46	$4.94	$4.60	$4.79	$4.52	$4.48	$4.38	$4.41	$4.56
Tangible Book Value per Share	$5.26	$4.63	$3.93	$3.39	$2.84	$2.04	$1.76	$1.74	$1.67	$1.70	$1.86
Total Capital	359	330	296	277	262	278	263	269	266	274	281
Total Debt	11	9.25	7.90	14	15	14	11	16	14	19	16
Total Long-Term Debt	4.93	3.77	2.73	6.69	8.06	6.85	5.40	8.69	7.30	10	8.15
Net Debt	-230	-200	-169	-136	-113	-90	-76	-63	-67	-63	-68
Capital Expenditures (CapEx)	5.85	6.73	6.60	6.08	5.84	5.31	7.86	5.45	7.40	4.18	7.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	9.54	10	12	14	14	4.20	4.10	11	4.29	7.50	13
Debt-free Net Working Capital (DFNWC)	250	220	189	164	141	108	92	90	86	89	97
Net Working Capital (NWC)	245	214	183	157	134	101	86	83	79	80	89
Net Nonoperating Expense (NNE)	14	12	10	11	11	9.51	9.94	6.13	5.96	4.71	1.06
Net Nonoperating Obligations (NNO)	-230	-200	-169	-136	-113	-90	-76	-63	-67	-63	-68
Total Depreciation and Amortization (D&A)	6.32	7.18	7.38	7.42	7.15	7.78	8.52	6.93	7.55	8.47	6.99
Debt-free, Cash-free Net Working Capital to Revenue	3.89%	3.83%	4.23%	4.77%	4.32%	1.24%	1.15%	2.90%	1.10%	1.85%	3.12%
Debt-free Net Working Capital to Revenue	102.08%	83.72%	67.13%	54.46%	44.30%	31.84%	25.71%	24.18%	22.08%	22.03%	23.18%
Net Working Capital to Revenue	99.75%	81.63%	65.29%	52.15%	42.07%	29.84%	24.01%	22.11%	20.24%	19.84%	21.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.89)	($0.76)	($0.72)	($0.70)	($0.68)	($0.58)	($0.55)	($0.35)	($0.31)	($0.25)	($0.11)
Adjusted Weighted Average Basic Shares Outstanding	52.33M	52.61M	52.44M	53.35M	53.79M	55.25M	54.56M	56.67M	57.50M	57.89M	57.59M
Adjusted Diluted Earnings per Share	($0.89)	($0.76)	($0.72)	($0.70)	($0.68)	($0.58)	($0.55)	($0.35)	($0.31)	($0.25)	($0.11)
Adjusted Weighted Average Diluted Shares Outstanding	52.33M	52.61M	52.44M	53.35M	53.79M	55.25M	54.56M	56.67M	57.50M	57.89M	57.59M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	52.53M	52.75M	53.36M	53.66M	55.21M	55.63M	56.39M	57.40M	57.77M	58.12M	58.77M
Normalized Net Operating Profit after Tax (NOPAT)	-32	-28	-28	-27	-26	-22	-21	-14	-12	-9.69	-5.33
Normalized NOPAT Margin	-47.79%	-38.12%	-36.39%	-31.64%	-30.14%	-24.48%	-21.79%	-13.43%	-11.81%	-9.07%	-4.86%
Pre Tax Income Margin	-68.52%	-54.66%	-49.87%	-44.40%	-42.08%	-34.46%	-32.03%	-18.98%	-16.90%	-13.07%	-4.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-224.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-157.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-253.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-185.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Phreesia, Inc. (NYSE: PHR) has shown a steady increase in operating revenue over the past two years, with revenues growing from approximately $55.9 million in Q3 2022 to around $109.7 million in Q4 2025. This represents a near doubling of revenue, indicating sustained top-line growth.

Despite revenue growth, the company continues to incur substantial net losses each quarter. Net income has improved somewhat, moving from a loss of about $40.2 million in Q3 2023 to a loss of $6.39 million in Q4 2025, reflecting narrowing losses but no profitability yet. Earnings per share improved from approximately -$0.76 per share in Q3 2023 to -$0.11 in Q4 2025.

The gross profit margin has been generally stable but modest, typically around 55%-60%. Operating expenses remain high, with significant expenditures in sales & marketing and research & development. For example, in Q4 2025 marketing and R&D expenses combined were around $58 million, which, while supporting growth, contributes to ongoing operating losses.

On the cash flow side, operating cash flow has significantly improved. While the company experienced operating cash outflows as recently as Q1 2024 (-$13.7 million), by Q4 2025, net cash from operating activities was positive at approximately $16.3 million. This indicates improving core business cash generation.

Investment activities have seen consistent moderate investments in property, plant, and equipment, around $4 million to $8 million quarterly, which suggests ongoing investment in infrastructure to support growth.

Financing activities show regular equity issuances offset by debt repayments and other financing outflows. Equity raises support cash needs, though financing cash flows remain negative, consistent with the company’s growth investment phase.

Balance sheet strength is supported by growing current assets, mainly cash & equivalents and accounts receivable. For instance, cash & equivalents stood at roughly $81.7 million in Q3 2025 and accounts receivable at about $71.4 million. Total liabilities have increased but remain manageable compared to equity, with total equity around $254.6 million as of Q3 2025, indicating a reasonable capital structure.

Operating revenue nearly doubled from $55.9M in Q3 2022 to $109.7M in Q4 2025, showing strong top-line growth.
Operating cash flow turned positive by Q4 2025 at $16.3 million, signaling improved cash generation.
Consistent investments in PPE demonstrate commitment to long-term growth infrastructure.
Equity financing supports operational needs and growth investments.
Gross profit margins remain steady but moderate around 55%-60%.
Sales & marketing and R&D expenses remain high, typical for a growth-stage tech company.
Accounts receivable and cash balances have grown, reflecting expanding operations.
Company continues to report net losses every quarter, though losses have narrowed.
Earnings per share remain negative, with recent Q4 2025 EPS of -$0.11.
Financing cash flows are negative overall, indicating ongoing capital needs.

In summary, Phreesia is demonstrating strong revenue growth and improving cash flow generation, suggesting progress towards profitability. However, it remains unprofitable with high operating expenses and negative earnings per share. Investors should weigh the growth potential against ongoing losses and cash burn risk.

10/08/25 02:20 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Phreesia's Financials

When does Phreesia's fiscal year end?

According to the most recent income statement we have on file, Phreesia's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Phreesia's net income changed over the last 7 years?

Phreesia's net income appears to be on an upward trend, with a most recent value of -$58.53 million in 2025, rising from -$18.19 million in 2018. The previous period was -$136.89 million in 2024. View Phreesia's forecast to see where analysts expect Phreesia to go next.

What is Phreesia's operating income?

Phreesia's total operating income in 2025 was -$58.10 million, based on the following breakdown:

Total Gross Profit: $284.88 million
Total Operating Expenses: $342.98 million

How has Phreesia's revenue changed over the last 7 years?

Over the last 7 years, Phreesia's total revenue changed from $79.83 million in 2018 to $419.81 million in 2025, a change of 425.9%.

How much debt does Phreesia have?

Phreesia's total liabilities were at $123.61 million at the end of 2025, a 4.0% increase from 2024, and a 93.9% increase since 2019.

How much cash does Phreesia have?

In the past 6 years, Phreesia's cash and equivalents has ranged from $1.54 million in 2019 to $313.81 million in 2022, and is currently $84.22 million as of their latest financial filing in 2025.

How has Phreesia's book value per share changed over the last 7 years?

Over the last 7 years, Phreesia's book value per share changed from 0.00 in 2018 to 4.56 in 2025, a change of 455.6%.

Related Companies

This page (NYSE:PHR) was last updated on 10/8/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phreesia (PHR) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Phreesia's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Phreesia (PHR) Financials

Annual Income Statements for Phreesia

Quarterly Income Statements for Phreesia

Annual Cash Flow Statements for Phreesia

Quarterly Cash Flow Statements for Phreesia

Annual Balance Sheets for Phreesia

Quarterly Balance Sheets for Phreesia

Annual Metrics And Ratios for Phreesia

Quarterly Metrics And Ratios for Phreesia

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Phreesia's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools